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During a heart attack, the heart is temporarily deprived of oxygen (ischemia) due to decreased blood 
flow and oxygen consumption necessarily decreases.  When blood flow is restored (reperfusion), 
oxygen consumption increases to levels higher than before injury, and this can cause severe 
damage to the heart muscle.  Previous work has shown that this form heart damage may be caused 
by altered redox chemistry, and elemental reducing agents such as sulfide and selenide can 
suppress increased oxygen consumption and reduce heart damage during reperfusion. Staff 
scientist Akiko Iwata and colleagues in the laboratory of Dr. Mark Roth (Basic Sciences Division) 
thus tested the protective effects of iodide, an additional elemental reducing agent, during 
reperfusion after ischemia.  They found that heart damage was reduced by up to 75% when iodide 
was administered intravenously after loss of blood flow but before reperfusion.  "This study suggests 
a new and important role for iodide in heart medicine," said Dr. Roth. 
The authors first examined the effect of iodide in acute myocardial infarction (heart attack) using a 
mouse model of myocardial ischemia reperfusion (MIR).  In this model, ischemia is induced 
surgically.  After 60 minutes of ischemia, mice are reperfused. Animals infused with iodide 5 minutes 
prior to the end of ischemia showed a 75% decrease in the size of the infarction (heart damage) 
compared with controls after either 2 or 24 hours of reperfusion.  Strikingly, oral administration of 
iodide to mice via drinking water for two days prior to induction of myocardial infarction also 
significantly reduced heart damage.  This effect was limited to the reduced form of iodine, iodide, as 
no benefit was seen with the oxidized form of iodine, iodate. 
The main mammalian processes involving iodine are related to the thyroid, and so the authors next 
tested whether thyroid function was required for the iodide benefit during reperfusion. The thyroid 
function of mice was restricted through a low iodine diet containing an additional chemical inhibitor of 
thyroid function. After three months of suppression of thyroid function, mice no longer saw benefits 
after reperfusion, arguing that normal thyroid function is needed for this effect of iodide. 
Iodine is a halogen, and so the authors tested for potential protective effects of additional halogens 
in MIR model. While confounding factors prevented the authors from testing the effects of chlorine 
and astatine, reduced bromine (bromide) reduced infarct size after reperfusion, though to a lesser 
extent than iodide. 
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The efficacy of iodide and its oral bioavailability in the MIR model of reperfusion, as well as its 
established safety, suggest that it is a promising therapeutic agent for the mitigation of reperfusion 
injury in humans.  However, the mechanism(s) by which iodide confers benefit during reperfusion is 
not clear.  The requirement for normal thyroid function for the protective effect of iodide suggests 
that thyroid hormones or metabolites might be involved. Indeed, the amount of iodide administered 
in this study has previously been shown to reduce thyroid hormone synthesis and secretion in what 
is known as the Wolff-Chaikoff effect.  As thyroid hormone stimulates metabolism, the suppression 
of its synthesis and secretion may decrease cardiac metabolism, leading to decreased heart 
damage during reperfusion.  The decreased effect of bromide in preventing reperfusion injury is 
consistent with this: bromide levels are low in the thyroid and would thus be unable to substantially 
reduce thyroid function.  Overall, this study highlights as a potentially safe and powerful agent for the 
prevention of reperfusion injury and indicates the value of future studies in this area. 
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Image modified from the publication 
Experimental scheme used in this study. Surgery was performed 
to occlude blood flow to the heart. After 60 minutes of ischemia, 
120 minutes or 24 hours of reperfusion were performed. Iodide 
was administered 5 minutes prior to reperfusion. 
 
